Daily Stock Analysis, ACRS, Aclaris Therapeutics Inc, priceseries

Aclaris Therapeutics Inc. Daily Stock Analysis
Stock Information
Open
17.53
Close
18.01
High
18.11
Low
17.27
Previous Close
17.33
Daily Price Gain
0.68
YTD High
30.38
YTD High Date
Apr 8, 2021
YTD Low
5.65
YTD Low Date
Jan 13, 2021
YTD Price Change
11.53
YTD Gain
177.93%
52 Week High
30.38
52 Week High Date
Apr 8, 2021
52 Week Low
2.25
52 Week Low Date
Sep 24, 2020
52 Week Price Change
15.61
52 Week Gain
650.42%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
May 10. 2018
18.21
May 21. 2018
19.17
7 Trading Days
5.27%
Link
LONG
Apr 22. 2019
5.88
Apr 30. 2019
6.40
6 Trading Days
8.88%
Link
LONG
Sep 16. 2019
1.10
Sep 23. 2019
1.32
5 Trading Days
20.08%
Link
LONG
Sep 25. 2020
2.46
Oct 26. 2020
3.99
21 Trading Days
62.37%
Link
LONG
Dec 10. 2020
3.79
Jan 6. 2021
6.43
17 Trading Days
69.71%
Link
LONG
Jan 19. 2021
18.83
Jan 20. 2021
21.55
1 Trading Days
14.47%
Link
LONG
Jan 27. 2021
18.44
Feb 18. 2021
22.63
15 Trading Days
22.71%
Link
LONG
Mar 31. 2021
25.20
Apr 12. 2021
27.53
7 Trading Days
9.25%
Link
Company Information
Stock Symbol
ACRS
Exchange
NasdaqGS
Company URL
http://www.aclaristx.com
Company Phone
484-321-5554
CEO
Neal S. Walker
Headquarters
Pennsylvania
Business Address
SUITE 400, 101 LINDENWOOD DRIVE, MALVERN, PA 19355
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001557746
About

Aclaris Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company, which engages in identifying, developing and commercializing novel drugs to address unmet needs in dermatology. It also pursues the development of topical agents for the treatment and prevention of a number of medical and cosmetic indications. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala and Stuart D. Shanler in July 2012 and is headquartered in Malvern, PA.

Description

Developing a proprietary hydrogen peroxide treatment for common skin lesions.